Hyperfine, Inc. (HYPR)
0.761
-0.04
(-4.89%)
USD |
NASDAQ |
Oct 15, 14:56
Hyperfine Total Assets (Quarterly) : 63.00M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.00M |
| March 31, 2026 | 60.34M |
| December 31, 2025 | 55.26M |
| September 30, 2025 | 41.51M |
| June 30, 2025 | 45.23M |
| March 31, 2025 | 53.38M |
| December 31, 2024 | 58.90M |
| September 30, 2024 | 69.39M |
| June 30, 2024 | 76.61M |
| March 31, 2024 | 85.44M |
| December 31, 2023 | 94.20M |
| September 30, 2023 | 103.06M |
| Date | Value |
|---|---|
| June 30, 2023 | 112.61M |
| March 31, 2023 | 122.10M |
| December 31, 2022 | 134.05M |
| September 30, 2022 | 148.33M |
| June 30, 2022 | 161.71M |
| March 31, 2022 | 178.83M |
| December 31, 2021 | 202.47M |
| September 30, 2021 | 207.94M |
| June 30, 2021 | 208.25M |
| March 31, 2021 | 208.45M |
| December 31, 2020 | 71.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 109.22B |
| AngioDynamics, Inc. | 241.93M |
| Alphatec Holdings, Inc. | 791.03M |
| AtriCure, Inc. | 676.64M |
| Baxter International, Inc. | 19.79B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.24M |
| Shareholders Equity (Quarterly) | 36.76M |
| Debt to Equity Ratio | 0.3649 |
| Current Ratio | 6.152 |
| Net Debt Paydown Yield | -1.83% |